| Also known as |
Doxazosin mesylate |
| Blood pressure |
Reduces both systolic and diastolic blood pressure |
| Chemical name |
1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazine |
| Dosage (medical) |
1-16 mg per day, depending on the condition being treated |
| Dosage (sports) |
Not applicable |
| Effects |
Reduces blood pressure and improves symptoms of enlarged prostate |
| Formula |
C23H25N5O5 |
| Half-life |
22 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Not specifically associated with regular lab tests, but blood pressure should be monitored |
| Main action |
Lowers blood pressure by relaxing blood vessels |
| Side effects |
Dizziness, fatigue, headache, hypotension, palpitations |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Substance class |
Alpha-1 adrenergic receptor blocker |
| Trade name |
Cardura, others |
| Use in sports |
Not typically used in sports |
| Water Retention |
Minimal to none |
| Manufacturer |
Pfizer |
| Packing |
2 MG 20 TB |
